ORCA
Online Research @ Cardiff
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 8.
Kadri, Hachemi, Taher, Taher E., Xu, Qin, Sharif, Maria, Ashby, Elizabeth, Bryan, Richard T., Willcox, Benjamin E. and Mehellou, Youcef  ORCID: https://orcid.org/0000-0001-5720-8513
2020.
Aryloxy diester phosphonamidate prodrugs of phosphoantigens (ProPAgens) as potent activators of Vγ9/Vδ2 T-Cell immune responses.
Journal of Medicinal Chemistry
63
(19)
, pp. 11258-11270.
10.1021/acs.jmedchem.0c01232
|
|
|
|
Miccoli, Ageo, Dhiani, Binar A., Thornton, Peter J., Lambourne, Olivia A., James, Edward, Kadri, Hachemi and Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513
2020.
Aryloxy triester phosphoramidates as phosphoserine prodrugs: a proof of concept study.
ChemMedChem
15
(8)
, pp. 671-674.
10.1002/cmdc.202000034
|
|
|
|
AlAmri, Mubarak A, Kadri, Hachemi, Jeeves, Mark, Alderwick, Luke J and Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513
2018.
The photosensitizing clinical agent verteporfin is an inhibitor of SPAK and OSR1 kinases.
ChemBioChem
19
(19)
, pp. 2072-2080.
10.1002/cbic.201800272
|
|
|
|
Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513, Alamri, Mubarak A., Dhiani, Binar A. and Kadri, Hachemi
2018.
C -terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25.
Biochemical and Biophysical Research Communications
503
(3)
, pp. 1868-1873.
10.1016/j.bbrc.2018.07.128
|
|
|
|
Kadri, Hachemi, Lambourne, Olivia A and Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513
2018.
Niclosamide, a drug with many (re)purposes.
ChemMedChem
13
(11)
, pp. 1088-1091.
10.1002/cmdc.201800100
|
|
|
|
Barini, Erica, Miccoli, Ageo, Tinarelli, Federico, Mulholand, Katie, Kadri, Hachemi, Khanim, Farhat, Stojanovski, Laste, Read, Kevin D, Burness, Kerry, Blow, Julian J, Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513 and Muqit, Miratul
2018.
The anthelmintic drug niclosamide and its analogues activate the Parkinson's Disease associated protein kinase PINK1.
Chembiochem
19
(5)
, pp. 425-429.
10.1002/cbic.201700500
|
|
|
Salim, Mahboob, Knowles, Timothy J., Baker, Alfie T., Davey, Martin S., Jeeves, Mark, Sridhar, Pooja, Wilkie, John, Willcox, Carrie R., Kadri, Hachemi, Taher, Taher E, Vantourout, Pierre, Hayday, Adrian, Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513, Mohammed, Fiyaz and Willcox, Benjamin E.
2017.
BTN3A1 discriminates γδ T cell phosphoantigens from non-antigenic small molecules via a conformational sensor in its B30.2 domain.
ACS Chemical Biology
12
(10)
, pp. 2631-2643.
10.1021/acschembio.7b00694
|
|
|
|
AlAmri, Mubarak A., Kadri, Hachemi, Dhiani, Binar Asrining, Mahmood, Shumail, Elzwawi, Abdulrahman and Mehellou, Youcef ORCID: https://orcid.org/0000-0001-5720-8513
2017.
WNK-signaling inhibitors as potential new antihypertensive drugs.
Chemmedchem
10.1002/cmdc.201700425
|
|
|